0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Intermediates Market by Type (Antibiotic, Hormone, Peptide), Application (Anti Diabetic, Anti Infective, Cardiovascular), Process Type, End User - Global Forecast 2025-2030- Product Image
Pharmaceutical Intermediates Market by Type (Antibiotic, Hormone, Peptide), Application (Anti Diabetic, Anti Infective, Cardiovascular), Process Type, End User - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Intermediates Market by Type (Antibiotic, Hormone, Peptide), Application (Anti Diabetic, Anti Infective, Cardiovascular), Process Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968712
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical intermediates market is poised for significant transformation, shaped by rising demand for high-purity building blocks, evolving regulatory landscapes, and technological advancements. As manufacturers confront complex operational and competitive pressures, senior leaders must align with emerging trends to secure sustainable growth and resilience.

Market Snapshot: Pharmaceutical Intermediates Market Performance

The Pharmaceutical Intermediates Market grew from USD 33.99 billion in 2024 to USD 36.86 billion in 2025, and is forecast to reach USD 54.60 billion by 2030 at a CAGR of 8.22%. Expansion is driven by global demand for innovative and cost-effective intermediates, the ongoing shift toward biosimilar and specialty pipelines, and rapid advances in digital manufacturing and process optimization. As regulatory complexity grows and providers invest more in green chemistry and quality systems, the market landscape is becoming more dynamic and diversified.

Scope & Segmentation

This report provides detailed analysis and forecasts across the key segments and regions defining the pharmaceutical intermediates industry. The breadth includes all major chemical types, application areas, process methodologies, end-user profiles, and regional geographies.

  • Type: Antibiotic—Beta Lactam, Macrolide, Quinolone, Tetracycline; Hormone; Peptide; Steroid; Vitamin
  • Application: Anti Diabetic; Anti Infective; Cardiovascular; Central Nervous System; Oncology—Cytotoxic, Hormonal Therapy, Immunotherapy, Targeted Therapy
  • Process Type: Biocatalysis; Chemical Synthesis; Fermentation—Bacterial, Fungal, Yeast
  • End User: Contract Manufacturing Organizations; Pharmaceutical Companies; Research Organizations
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, among others); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)

Key companies analyzed include Lonza Group AG, Evonik Industries AG, Merck KGaA, BASF SE, Cambrex Corporation, Wuxi AppTec Co., Ltd., Albemarle Corporation, Johnson Matthey PLC, Zhejiang Huahai Pharmaceutical Co., Ltd., and Hubei Biocause Pharmaceutical Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Leading pharmaceutical companies are prioritizing digital transformation, modular manufacturing, and green chemistry to meet evolving customer and regulatory demands.
  • The competitive environment is marked by collaborations and strategic acquisitions, especially as established players seek technology upgrades and regional expansion.
  • Contract manufacturing organizations play an increasingly central role, offering specialized, turnkey solutions and supporting both established firms and research-driven entities.
  • Therapeutic innovation—including a focus on new anti-diabetic, anti-infective, cardiovascular, and oncology segments—is influencing the diversity and specialization of intermediates produced.
  • Diversified supplier networks and flexible manufacturing strategies mitigate risk and increase responsiveness to policy changes and market volatility.
  • Sustainability initiatives, such as the adoption of eco-friendly reagents and improved process efficiencies, are becoming benchmarks for operational excellence and future investment.

Tariff Impact: Navigating Trade and Cost Structure Challenges

The introduction of United States tariffs in 2025 represents a substantial shift in global supply chains for pharmaceutical intermediates. Manufacturers are actively reassessing sourcing, renegotiating contracts, and exploring nearshoring and regional diversification to reduce exposure and maintain supply continuity. Investments in advanced process technologies are also underway to offset cost pressures resulting from tariff adjustments. Organizations focused on risk mitigation, scenario planning, and strategic supplier mapping will be best equipped to manage the resulting disruptions and cost structure changes.

Methodology & Data Sources

This analysis integrates qualitative interviews with industry executives, engineers, and regulatory officials, alongside site visits for operational insight. Secondary sources include regulatory filings, patent literature, academic and trade publications, and statistical modeling of investment and trade data. A robust peer review process supports the reliability and validity of segmentation and regional findings.

Why This Report Matters

  • Equips senior executives with a comprehensive understanding of the latest trends, technology adoption, and regulatory changes impacting pharmaceutical intermediates.
  • Provides actionable guidance for strategic planning, risk mitigation, and operational investment, tailored for decision-making at the highest organizational levels.
  • Supports competitive benchmarking against industry leaders and peer organizations in the adoption of sustainable, efficient, and resilient business models.

Conclusion

Stakeholders in the pharmaceutical intermediates market face both challenges and unprecedented opportunities as innovation, global trade, and regulatory landscapes evolve. This report delivers a practical roadmap for informed decision-making and long-term strategic advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of continuous flow manufacturing processes for pharmaceutical intermediates to enhance efficiency and safety
5.2. Increasing integration of green chemistry principles to minimize environmental impact of intermediate synthesis
5.3. Rising demand for peptide and oligonucleotide intermediates driven by expansion of biologic drug pipelines
5.4. Strategic consolidation among contract development and manufacturing organizations to strengthen supply chain resilience
5.5. Implementation of advanced process analytics and AI-driven optimization for scalable intermediate production
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Intermediates Market, by Type
8.1. Introduction
8.2. Antibiotic
8.2.1. Beta Lactam
8.2.2. Macrolide
8.2.3. Quinolone
8.2.4. Tetracycline
8.3. Hormone
8.4. Peptide
8.5. Steroid
8.6. Vitamin
9. Pharmaceutical Intermediates Market, by Application
9.1. Introduction
9.2. Anti Diabetic
9.3. Anti Infective
9.4. Cardiovascular
9.5. Central Nervous System
9.6. Oncology
9.6.1. Cytotoxic
9.6.2. Hormonal Therapy
9.6.3. Immunotherapy
9.6.4. Targeted Therapy
10. Pharmaceutical Intermediates Market, by Process Type
10.1. Introduction
10.2. Biocatalysis
10.3. Chemical Synthesis
10.4. Fermentation
10.4.1. Bacterial
10.4.2. Fungal
10.4.3. Yeast
11. Pharmaceutical Intermediates Market, by End User
11.1. Introduction
11.2. Contract Manufacturing Organizations
11.3. Pharmaceutical Companies
11.4. Research Organizations
12. Americas Pharmaceutical Intermediates Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pharmaceutical Intermediates Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pharmaceutical Intermediates Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Lonza Group AG
15.3.2. Evonik Industries AG
15.3.3. Merck KGaA
15.3.4. BASF SE
15.3.5. Cambrex Corporation
15.3.6. Wuxi AppTec Co., Ltd.
15.3.7. Albemarle Corporation
15.3.8. Johnson Matthey PLC
15.3.9. Zhejiang Huahai Pharmaceutical Co., Ltd.
15.3.10. Hubei Biocause Pharmaceutical Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL INTERMEDIATES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PHARMACEUTICAL INTERMEDIATES MARKET: RESEARCHAI
FIGURE 24. PHARMACEUTICAL INTERMEDIATES MARKET: RESEARCHSTATISTICS
FIGURE 25. PHARMACEUTICAL INTERMEDIATES MARKET: RESEARCHCONTACTS
FIGURE 26. PHARMACEUTICAL INTERMEDIATES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BETA LACTAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BETA LACTAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY MACROLIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY MACROLIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY QUINOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY QUINOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TETRACYCLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY HORMONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY HORMONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STEROID, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STEROID, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY VITAMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY VITAMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTI DIABETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTI DIABETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTI INFECTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTI INFECTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CYTOTOXIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CYTOTOXIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FUNGAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 112. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 113. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 116. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 117. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 126. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 127. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 130. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 131. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 196. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 197. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 198. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 199. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 202. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 203. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 210. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 211. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 212. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 213. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 216. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 217. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 238. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 239. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 240. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 241. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 244. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 245. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 252. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 253. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 254. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 255. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 258. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 259. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 302. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 304. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 308. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 309. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2024 (USD MILLION)
TABLE 310. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2025-2030 (USD MILLION)
TABLE 311. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 314. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 315. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 316. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 317. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
TABLE 318. DENMARK PHARMACEUTICAL INTERMEDI

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

  • Lonza Group AG
  • Evonik Industries AG
  • Merck KGaA
  • BASF SE
  • Cambrex Corporation
  • Wuxi AppTec Co., Ltd.
  • Albemarle Corporation
  • Johnson Matthey PLC
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
  • Hubei Biocause Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 36.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.6 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pharmaceutical Intermediates Global Market Report 2025 - Product Image

Pharmaceutical Intermediates Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Active Pharmaceutical Ingredients CDMO Market by Service Type, Molecule Type, Production Scale, Therapeutic Area, Manufacturing Technology - Global Forecast 2025-2030 - Product Image

Active Pharmaceutical Ingredients CDMO Market by Service Type, Molecule Type, Production Scale, Therapeutic Area, Manufacturing Technology - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Pharmaceutical Intermediates - Global Strategic Business Report - Product Image

Pharmaceutical Intermediates - Global Strategic Business Report

  • Report
  • 297 Pages
  • Global
From
EUR$5,850USDGBP
Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
EUR$4,750USDGBP
High Potency Active Pharmaceutical Ingredients Market by Type (Biologics, Small Molecule), Therapeutic Area (Cardiology, Infectious Disease, Neurology), Source, Dosage Form, Manufacturing Process, End User - Global Forecast 2025-2030 - Product Image

High Potency Active Pharmaceutical Ingredients Market by Type (Biologics, Small Molecule), Therapeutic Area (Cardiology, Infectious Disease, Neurology), Source, Dosage Form, Manufacturing Process, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP

About the Pharmaceutical Intermediates Market

The Pharmaceutical Intermediates market is a segment of the pharmaceutical industry that focuses on the production of intermediate compounds used in the manufacture of drugs. These intermediates are typically produced in bulk and are used in the synthesis of active pharmaceutical ingredients (APIs). Pharmaceutical intermediates are typically produced in large quantities and are used in the production of a wide range of drugs, including antibiotics, antifungals, antivirals, and anti-inflammatory agents. The Pharmaceutical Intermediates market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. These companies are involved in the production of a variety of intermediates, including amino acids, peptides, carbohydrates, and lipids. Additionally, many of these companies are involved in the development of new intermediates for the production of novel drugs. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more